Jakob Lauritsen

13PUBLICATIONS
46CO-AUTHORS
Family and household studiesPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 02, 2026
Risk of childhood and adolescent, and young adult cancer in offspring of men with testicular cancer: A Danish nationwide study.

Mikkel Bandak, Susanne Rosthøj, Gitte Lerche Aalborg

|Feb 19, 2026
A Unified Machine Learning Model for Relapse Prediction in Clinical Stage I Testicular Cancer.

Thomas Wagner, Ramtin Zargari Marandi, Jakob Lauritsen

|Sep 25, 2025
Clinical implementation of intensity modulated proton therapy for testicular seminoma.

Heidi S Rønde, Jesper F Kallehauge, Morten Høyer

|Jul 03, 2025
An example of drug repurposing: ebastine in combination with docetaxel as a treatment for metastatic castration-resistant prostate cancer-the EXUROC prostate study, a clinical trial protocol.

Katrine Ørum, Dag R Stormoen, Jakob Lauritsen

|Jan 31, 2025
Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide study.

Niklas B Lindahl, Jakob Lauritsen, Thomas Wagner

|Sep 30, 2023
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.

Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin

Pageof 3

Frequent Collaborators

7 joint publications

Gedske Daugaard

6 joint publications

Mikkel Bandak

4 joint publications

Thomas Wagner

3 joint publications

Michael Kreiberg